U.S. flag

An official website of the United States government

NM_021957.4(GYS2):c.942-7del AND Glycogen storage disorder due to hepatic glycogen synthase deficiency

Germline classification:
Conflicting interpretations of pathogenicity (2 submissions)
Last evaluated:
Oct 29, 2023
Review status:
criteria provided, conflicting classifications
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000300407.11

Allele description [Variation Report for NM_021957.4(GYS2):c.942-7del]

NM_021957.4(GYS2):c.942-7del

Gene:
GYS2:glycogen synthase 2 [Gene - OMIM - HGNC]
Variant type:
Deletion
Cytogenetic location:
12p12.1
Genomic location:
Preferred name:
NM_021957.4(GYS2):c.942-7del
HGVS:
  • NC_000012.12:g.21563045del
  • NG_016167.1:g.46803del
  • NM_021957.4:c.942-7delMANE SELECT
  • LRG_1293t1:c.942-7del
  • LRG_1293:g.46803del
  • NC_000012.11:g.21715979del
  • NM_021957.3:c.942-7delG
Links:
dbSNP: rs537907545
NCBI 1000 Genomes Browser:
rs537907545
Molecular consequence:
  • NM_021957.4:c.942-7del - intron variant - [Sequence Ontology: SO:0001627]

Condition(s)

Name:
Glycogen storage disorder due to hepatic glycogen synthase deficiency
Synonyms:
GSD 0a; LIVER GLYCOGEN SYNTHASE DEFICIENCY; Hypoglycemia with deficiency of glycogen synthetase in the liver; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0009414; MedGen: C1855861; Orphanet: 2089; OMIM: 240600

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000377441Illumina Laboratory Services, Illumina
criteria provided, single submitter

(ICSL Variant Classification 20161018)
Uncertain significance
(Jun 14, 2016)
germlineclinical testing

ICSL_Variant_Classification_20161018.pdf,

Citation Link,

SCV002344210Invitae
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Benign
(Oct 29, 2023)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria.

Nykamp K, Anderson M, Powers M, Garcia J, Herrera B, Ho YY, Kobayashi Y, Patil N, Thusberg J, Westbrook M; Invitae Clinical Genomics Group., Topper S.

Genet Med. 2017 Oct;19(10):1105-1117. doi: 10.1038/gim.2017.37. Epub 2017 May 11. Erratum in: Genet Med. 2020 Jan;22(1):240. doi: 10.1038/s41436-019-0624-9.

PubMed [citation]
PMID:
28492532
PMCID:
PMC5632818

Details of each submission

From Illumina Laboratory Services, Illumina, SCV000377441.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Invitae, SCV002344210.3

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: May 19, 2024